Does Spravato Cause Weight Gain? What the Science Actually Says
If you are exploring Spravato as a treatment for treatment resistant depression, you have probably spent time on Google reading about side effects. One question comes up again and again in our intake conversations at Serenada Mental Health, and it is a fair one. People want to know how a new medication will affect their bodies, and weight is one of the most personal and most loaded concerns a patient can raise. After years of dealing with the weight gain that often comes with SSRIs and other oral antidepressants, the last thing anyone wants is to trade depression for an entirely new problem on the scale.
So, does Spravato cause weight gain? The honest answer is that the clinical evidence does not show weight gain as a common side effect of Spravato. In the FDA approval trials, weight changes were not among the most frequently reported adverse events. But the question deserves more than a one line answer, because the relationship between depression, antidepressants, body weight, and esketamine is more complicated than a single data point can capture. In this article, we will walk through what the FDA prescribing information actually reports, what patients in real world settings describe, why indirect factors can still lead to weight changes during Spravato treatment, and how to talk with your clinician if the scale starts moving in a direction you did not expect.
Does Spravato Cause Weight Gain? The Short Answer
Let us start with the clearest statement the data supports. According to the FDA prescribing information for Spravato, weight gain is not listed as a common side effect of the medication. The most frequently reported adverse reactions in clinical trials were dissociation, dizziness, nausea, sedation, vertigo, anxiety, increased blood pressure, vomiting, and a feeling of being drunk. Nausea and vomiting, if anything, are more likely to produce a slight decrease in appetite during the hours surrounding a dose than a sustained increase in weight over the course of treatment.
It is also worth noting that long term open label extension studies of Spravato, which followed patients for up to a year of treatment, did not flag clinically significant weight gain as a major safety signal. This does not mean no individual patient ever gains weight while on Spravato. It means that, in the aggregate, weight gain has not emerged as a characteristic side effect of the medication the way it has for some oral antidepressants. So when patients ask us, does Spravato cause weight gain, our evidence based answer is that the data does not support a strong direct link, and that any weight changes that do occur during treatment usually have other explanations worth investigating.
The Actual Side Effects of Spravato
To put the weight question in context, it helps to understand what Spravato side effects actually look like. The medication is administered as a nasal spray in a REMS certified clinic, and most side effects occur during or shortly after the dosing session rather than building up over weeks and months the way oral medication side effects often do.
The most common side effects, as documented in the FDA label, include:
Dissociation, often described as a feeling of detachment from surroundings, body, or sense of time.
Dizziness and vertigo, typically peaking within the first hour after the dose.
Nausea, which in some cases can temporarily reduce appetite rather than stimulate it.
Sedation or sleepiness during the two hour observation period.
A transient increase in blood pressure, which is why every session includes clinical monitoring.
Anxiety, headache, or a feeling of being drunk, all of which generally resolve before discharge.
None of these effects are typically associated with sustained weight gain. In fact, the side effect profile of Spravato is quite different from that of oral antidepressants, which is one reason esketamine is sometimes preferred for patients who have struggled with weight changes on SSRIs or SNRIs. To walk through what a dosing session actually feels like, our guide to what actually happens during a Spravato session covers the entire experience in detail, including how side effects are monitored and managed in real time.
Why Weight Changes Can Still Happen During Spravato Treatment
If Spravato itself is not a common cause of weight gain, why do some patients still notice the scale shifting during treatment? The answer usually lies in indirect factors that have nothing to do with the medication itself but everything to do with the broader context of recovery from treatment resistant depression.
Improvement in Depression Itself
Depression alters appetite in both directions. Some people lose their appetite entirely and shed weight without trying. Others eat for comfort and gain. When depression begins to lift, whether through Spravato, therapy, or a combination of treatments, appetite often normalizes. If you had been undereating during a depressive episode, your appetite returning may produce weight gain that is actually a sign of healing rather than a side effect of the medication. If you had been overeating as a coping mechanism, the same improvement in mood might lead to weight loss. The direction of change depends on where you started, and it is rarely a simple story of medication causing weight gain.
Concurrent Oral Antidepressants
This is the factor most often overlooked. Spravato is FDA approved as an adjunct to an oral antidepressant, not as a standalone treatment. That means almost every patient receiving Spravato is also taking an SSRI, SNRI, bupropion, or another oral medication. Many of these drugs, particularly SSRIs like paroxetine and sertraline, are well known to cause weight gain over time. If you gain weight during Spravato treatment, the more likely culprit is often the oral antidepressant in your regimen rather than the esketamine itself. This is exactly the kind of question your psychiatric provider should help you investigate, because adjusting the oral medication is often a more effective solution than discontinuing Spravato.
Lifestyle Changes During Recovery
As depression improves, patients often return to activities and routines that had fallen away during the worst of the illness. That can mean eating out more often, socializing over meals, drinking alcohol again, or simply having the energy to cook richer foods. These are positive signs of recovery, but they can produce weight gain that has nothing to do with the medication. Honest self reflection about lifestyle changes is an important part of figuring out what is actually driving any shift on the scale.
Stress, Sleep, and Cortisol
Chronic stress and poor sleep both elevate cortisol, which in turn promotes abdominal fat storage. Many patients arrive at Spravato treatment in a state of significant physiological dysregulation. Even as mood improves, the body can take longer to rebalance. If you notice weight changes during the early months of treatment, stress and sleep architecture are worth examining alongside the medication itself.
How Spravato Compares to Other Antidepressants on Weight
To put the question in perspective, it helps to compare Spravato with the medications most patients have already tried. Antidepressant weight gain is one of the most common reasons patients abandon an otherwise effective medication. SSRIs, particularly paroxetine, are associated with an average weight gain of several pounds over the first six to twelve months of treatment. Mirtazapine is even more strongly associated with weight gain and increased appetite. SNRIs like venlafaxine and duloxetine are somewhat less likely to cause weight gain than SSRIs but still can in some patients. Bupropion is the oral antidepressant most often associated with weight neutrality or even mild weight loss.
Against that backdrop, Spravato is relatively weight neutral. The FDA clinical trial data did not show significant weight gain as a common adverse event, and the medication does not appear to act on the appetite regulating pathways that drive weight gain with some oral antidepressants. For patients whose previous antidepressant trials were derailed by weight gain, esketamine can sometimes be a better tolerated option. To understand how Spravato fits within the broader landscape of options for hard to treat depression, see our guide to advanced treatment options for depression.
What Real World Patients Actually Report
Clinical trial data is one thing. Real world experience is another. In our practice at Serenada Mental Health, we monitor patients closely throughout their Spravato course, and the picture that emerges is consistent with the trial data. Significant weight gain is not a complaint we hear often. When we do hear it, the most common explanations are the indirect factors we just reviewed: a concurrent oral antidepressant, the return of appetite as depression lifts, or lifestyle changes that accompany recovery.
Some patients actually report the opposite. As depression improves and energy returns, they become more physically active, more intentional about nutrition, and more engaged in self care. For these patients, Spravato treatment is associated with weight loss or weight stabilization rather than gain. Others find that nausea during the induction phase temporarily reduces appetite, though this typically resolves as the body adjusts to the medication. The honest summary is that weight response to Spravato is variable and individual, but dramatic weight gain is uncommon and rarely attributable to the medication alone.
How to Monitor Weight During Spravato Treatment
If you are starting Spravato and weight is a concern for you, there are practical steps you can take to monitor and manage the question proactively rather than waiting to see what happens.
Track your weight at the same time of day, on the same scale, once a week. Daily fluctuations are too noisy to be meaningful and tend to create unnecessary anxiety.
Keep a simple food and mood journal for the first eight weeks. Patterns often emerge that would otherwise go unnoticed, and the data is invaluable when talking with your clinician.
Note any changes to your oral antidepressant regimen. If your psychiatrist adjusts your SSRI or adds a new medication, that is often the more relevant variable than the Spravato itself.
Bring up weight concerns at every Spravato session. Your care team cannot help with a problem they do not know about, and weight is a legitimate clinical topic, not a vanity issue.
The patients who do best with Spravato are the ones who treat the medication as part of a broader recovery plan rather than a standalone intervention. Weight is one piece of that plan, and it deserves honest attention without becoming the lens through which every other aspect of treatment is judged.
When to Talk With Your Clinician
If you are already in Spravato treatment and you notice weight changes that concern you, reach out to your psychiatric provider. Do not wait for your next scheduled session if the change is rapid or accompanied by other symptoms. Sudden weight gain can sometimes signal fluid retention, thyroid changes, or other medical issues that have nothing to do with depression treatment and deserve prompt evaluation. Gradual weight gain over months is more likely to reflect medication or lifestyle factors and can be addressed at a regular appointment.
Be specific when you raise the concern. Tell your clinician how much weight you have gained or lost, over what period, and what else has changed in your life during that time. The more information you provide, the easier it is for your provider to identify the actual cause and recommend a solution. Sometimes the answer is as simple as adjusting an oral antidepressant. Sometimes it is a referral to a registered dietitian or a sleep specialist. Sometimes it is reassurance that the change is within the normal range of recovery and not a cause for alarm. Whatever the answer, you deserve a thoughtful conversation rather than a shrug.
Accessing Spravato Treatment in Georgetown and Waco, TX
If you are considering Spravato and you live in Central Texas, you no longer have to travel to Austin, Houston, or Dallas for REMS certified esketamine therapy. Serenada Mental Health offers Spravato treatment at both our Georgetown and Waco clinics, bringing interventional psychiatry closer to home for residents across the region. Whether you live in Georgetown, Waco, Round Rock, Temple, Belton, or the rural communities in between, qualified care is now within reach.
You can learn more about our protocol, our REMS certification, and what to expect on our Spravato treatment service page. For patients whose schedules or locations make regular in person visits challenging, our telehealth psychiatry in Texas offering extends much of the surrounding care into the home. While the Spravato doses themselves must be administered in person under clinical supervision, psychiatric follow up, medication management, and much of the psychotherapy can be delivered securely by video. We accept a broad range of insurance, including Medicare, TriWest and TriCare, and ChampVA, which is especially important for veterans and military families in our region.
The Bottom Line on Spravato and Weight
So, does Spravato cause weight gain? Based on the FDA clinical trial data and our experience treating patients in Central Texas, the answer is that weight gain is not a common or characteristic side effect of esketamine therapy. The side effects that do occur, such as dissociation, dizziness, nausea, and transient blood pressure increases, are typically tied to the dosing session itself and resolve within hours. When patients do experience weight changes during Spravato treatment, the explanation is far more often found in the recovery process itself, in concurrent oral antidepressants, or in lifestyle shifts than in the esketamine.
If weight gain has been a dealbreaker for you with previous antidepressants, that history should absolutely be part of the conversation when you evaluate Spravato. It may make esketamine an especially attractive option. If you are already in treatment and the scale is moving in a direction you did not expect, talk with your clinician. Most of the time, the cause is identifiable and addressable, and almost none of the time is it a reason to abandon a treatment that is otherwise working. The goal of depression care is not just symptom relief. It is the restoration of a life that feels worth living, and that includes a relationship with your body that is honest, sustainable, and kind.
Take the Next Step With Confidence
At Serenada Mental Health, we know that starting a new psychiatric medication is a significant decision, and we honor the questions and concerns you bring to that choice. Whether you are worried about weight, side effects, cost, or whether Spravato is even the right fit for your story, our role is to walk through those questions with you honestly, using the best available evidence and a clinical philosophy that treats you as a whole person rather than a diagnosis. Where healing begins with understanding, and where your concerns are taken seriously rather than dismissed.
Call us at (512) 612-9441 or click Book Now to schedule a comprehensive consultation at our Georgetown or Waco clinic. The clarity you have been looking for starts with a single conversation, and we would be honored to have it with you.
